A study presented at the American Heart Association’s scientific meetings has raised concerns about melatonin, one of Britain’s most commonly prescribed sleep aids. The findings suggest that long-term users face a higher risk of heart failure. But the preliminary data demands careful scrutiny before the alarm is sounded.